Literature DB >> 9311626

Human liver carboxylesterase hCE-1: binding specificity for cocaine, heroin, and their metabolites and analogs.

M R Brzezinski1, B J Spink, R A Dean, C E Berkman, J R Cashman, W F Bosron.   

Abstract

Purified human liver carboxylesterase (hCE-1) catalyzes the hydrolysis of cocaine to form benzoylecgonine, the deacetylation of heroin to form 6-acetylmorphine, and the ethanol-dependent transesterification of cocaine to form cocaethylene. In this study, the binding affinities of cocaine, cocaine metabolites and analogs, heroin, morphine, and 6-acetylmorphine for hCE-1 were evaluated by measuring their kinetic inhibition constants with 4-methylumbelliferyl acetate in a rapid spectrophotometric assay. The naturally occurring (R)-(-)-cocaine isomer displayed the highest affinity of all cocaine and heroin analogs or metabolites. The pseudo- or allopseudococaine isomers of cocaine exhibited lower affinity indicating that binding to the enzyme is stereoselective. The methyl ester, benzoyl, and N-methyl groups of cocaine play important roles in binding because removal of these groups increased K(i) values substantially. Compounds containing a variety of hydrophobic substitutions at the benzoyl group of cocaine bound to the enzyme with high affinity. The high K(i) value obtained for cocaethylene relative to cocaine is consistent with weaker binding to the esterase and a longer elimination half-life reported for the metabolite. The spectrophotometric competitive inhibition assay used here represents an effective method to identify drug or environmental esters metabolized by carboxylesterases like hCE-1.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311626

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Biochemical and molecular analysis of carboxylesterase-mediated hydrolysis of cocaine and heroin.

Authors:  M J Hatfield; L Tsurkan; J L Hyatt; X Yu; C C Edwards; L D Hicks; R M Wadkins; P M Potter
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

2.  Evaluation of a pharmacokinetic hypothesis for reduced locomotor stimulation from methamphetamine and cocaine in adolescent versus adult male C57BL/6J mice.

Authors:  Jonathan A Zombeck; Tripta Gupta; Justin S Rhodes
Journal:  Psychopharmacology (Berl)       Date:  2008-09-17       Impact factor: 4.530

3.  Facile synthesis of 1,2-dione-containing abietane analogues for the generation of human carboxylesterase inhibitors.

Authors:  Randall J Binder; M Jason Hatfield; Liying Chi; Philip M Potter
Journal:  Eur J Med Chem       Date:  2018-02-19       Impact factor: 6.514

Review 4.  Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.

Authors:  Elinore F McCance-Katz
Journal:  Life Sci       Date:  2010-10-19       Impact factor: 5.037

Review 5.  Interception of cocaine by enzyme or antibody delivered with viral gene transfer: a novel strategy for preventing relapse in recovering drug users.

Authors:  Stephen Brimijoin
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-12       Impact factor: 4.388

6.  Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis.

Authors:  S Casey Laizure; Robert B Parker; Vanessa L Herring; Zhe-Yi Hu
Journal:  Drug Metab Dispos       Date:  2013-11-08       Impact factor: 3.922

7.  Modulation of esterified drug metabolism by tanshinones from Salvia miltiorrhiza ("Danshen").

Authors:  M Jason Hatfield; Lyudmila G Tsurkan; Janice L Hyatt; Carol C Edwards; Andrew Lemoff; Cynthia Jeffries; Bing Yan; Philip M Potter
Journal:  J Nat Prod       Date:  2013-01-03       Impact factor: 4.050

8.  Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

Authors:  Latorya D Hicks; Janice L Hyatt; Shana Stoddard; Lyudmila Tsurkan; Carol C Edwards; Randy M Wadkins; Philip M Potter
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

Review 9.  Tumour-selective targeting of drug metabolizing enzymes to treat metastatic cancer.

Authors:  Monika Wierdl; Lyudmila Tsurkan; M Jason Hatfield; Philip M Potter
Journal:  Br J Pharmacol       Date:  2016-08-22       Impact factor: 8.739

10.  Metabolic Enzymes of Cocaine Metabolite Benzoylecgonine.

Authors:  Xiabin Chen; Xirong Zheng; Max Zhan; Ziyuan Zhou; Chang-Guo Zhan; Fang Zheng
Journal:  ACS Chem Biol       Date:  2016-06-09       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.